Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors-Reference-Cited by-同舟云学术

Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors

Published:2005-02-22 Issue:7 Volume:103 Page:1402-1407
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cantore Maurizio,Mambrini Andrea,Fiorentini Giammaria,Rabbi Carla,Zamagni Donatella,Caudana Roberto,Pennucci Cristina,Sanguinetti Franco,Lombardi Mirko,Nicoli Nicola

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Biliary tract cancer;De Groen;N Engl J Med.,1999

2. What constitutes long-term survival after surgery for hilar cholangiocarcinoma?;Klempnauer;Cancer.,1997

3. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors;Nakeeb;Ann Surg.,1996

4. Primary carcinoma of the gallbladder;Roberts;Surg Clin North Am.,1986

5. Recurrence after surgical resection of intrahepatic cholangiocarcinoma;Yamamoto;J Hepatobiliary Pancreat Surg.,2001

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma;Pharmaceuticals;2024-07-08

2. Cholangiocarcinoma;Cancer Treatment and Research;2024

3. Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?;Cancers;2023-08-23

4. Update on Locoregional Therapies for Cholangiocellular Carcinoma;Cancers;2023-04-19

5. Clinical outcomes of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and anti‐ PD ‐1 immunotherapy for unresectable intrahepatic cholangiocarcinoma;Journal of Digestive Diseases;2022-08